Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 4.0S - 11 mm: medical device reports filed with FDA

5,716 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

5,716
device reports naming the brand
0% of all MAUDE reports · about 807 a year
763
reports, 12 months to August 2026
767 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 5,716 reports that name the brand "OsseoSpeed TX 4.0S - 11 mm" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

763 reports arrived in the 12 months to August 2026, close to the 767 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (36.5%), loss of osseointegration (31.5%) and failure to osseointegrate (30.5%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

063126Sep 2021: 50Oct 2021: 62Nov 2021: 62Dec 2021: 692022Jan 2022: 86Feb 2022: 39Mar 2022: 82Apr 2022: 99May 2022: 72Jun 2022: 70Jul 2022: 53Aug 2022: 66Sep 2022: 54Oct 2022: 51Nov 2022: 68Dec 2022: 812023Jan 2023: 74Feb 2023: 62Mar 2023: 46Apr 2023: 53May 2023: 74Jun 2023: 70Jul 2023: 59Aug 2023: 98Sep 2023: 69Oct 2023: 56Nov 2023: 78Dec 2023: 422024Jan 2024: 76Feb 2024: 73Mar 2024: 70Apr 2024: 80May 2024: 62Jun 2024: 105Jul 2024: 83Aug 2024: 77Sep 2024: 72Oct 2024: 71Nov 2024: 63Dec 2024: 562025Jan 2025: 68Feb 2025: 36Mar 2025: 126Apr 2025: 26May 2025: 32Jun 2025: 58Jul 2025: 95Aug 2025: 64Sep 2025: 79Oct 2025: 57Nov 2025: 65Dec 2025: 572026Jan 2026: 84Feb 2026: 46Mar 2026: 53Apr 2026: 67May 2026: 63Jun 2026: 58Jul 2026: 103Aug 2026: 31

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

08921,7832019: 17520192021: 1,78320212022: 82120222023: 78120232024: 88820242025: 76320252026: 5052026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,716
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%5,716
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem2,08836.5%7.7%
Loss of osseointegration1,79931.5%22.4%
Failure to osseointegrate1,74530.5%62.8%
Fracturea broken bone961.7%1.6%
Loosening of implant not related to bone-ingrowth380.7%0.1%
Damaged thread110.2%0%
Crackthe device cracked60.1%0%
Insufficient device problem information40.1%0.2%
Malposition of device30.1%0.1%
Device dislodged or dislocated20%0%
Overfill10%0%
Patient-device incompatibilitythe device did not suit the patient10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant5,71099.9%
Inflammationinflammation84414.8%
Osteolysis3436%
Pocket erosion2875%
Implant pain110.2%
Painpain, site not specified50.1%
Discomfortdiscomfort40.1%
Inadequate osseointegration30.1%
Paresthesia20%
Appropriate clinical signs, symptoms and conditions term/code not available10%
Hypoesthesia10%
Laceration(s)10%
Sinus perforation10%
Swelling/ edema10%
Tinnitusringing in the ears10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 4.0S - 11 mmProduct code DZEAll MAUDE reports
Reports5,7163,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 4.0S - 11 mm reports

How many FDA reports name OsseoSpeed TX 4.0S - 11 mm?

5,716 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 763 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (36.5%), loss of osseointegration (31.5%), failure to osseointegrate (30.5%), fracture (1.7%) and loosening of implant not related to bone-ingrowth (0.7%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 4.0S - 11 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.